Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin for Subsolid Lung Nodules
NCT02169271Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Nov 2014
- Primary completion
- Jul 2018
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 2 trial of aspirin in lung cancer, sponsored by National Cancer Institute. Started Nov 2014; status: completed.
02
Drugs
aspirin
03
Conditions
lung cancer
Beyond the preview
Go deeper on NCT02169271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02169271.